Skip to main content
Editorial illustration for Raindrop's Experiments Tool Tests if AI Agent Updates Improve or Hurt Perform...

Editorial illustration for Raindrop Launches Platform to Streamline AI Agent Testing and Performance Tracking

Raindrop Launches AI Agent Testing Platform for Devs

Raindrop Tackles AI Agent Regressions With New Experimentation Platform

Updated: 3 min read

AI agents don’t crash. They don’t throw stack traces or blue screens. They just get a little worse, one update, one prompt tweak, one model swap at a time.

The regression is silent. It compounds. And by the time anyone notices, the damage is already baked into production.

Raindrop, the observability platform born out of that very “black box” problem, is now firing back with a new weapon: Experiments. This isn’t just another dashboard. It’s a system designed to inject the rigor of modern software deployment into the chaotic world of agent iteration.

Track outcomes. Share insights. Catch the regressions before they become the new normal.

Will your next agent update help or hamper performance? Raindrop’s answer: you’ll know, not guess.

By making this data easy to interpret, Raindrop encourages AI teams to approach agent iteration with the same rigor as modern software deployment—tracking outcomes, sharing insights, and addressing regressions before they compound. Background: From AI Observability to Experimentation Raindrop’s launch of Experiments builds on the company’s foundation as one of the first AI-native observability platforms, designed to help enterprises monitor and understand how their generative AI systems behave in production. As VentureBeat reported earlier this year, the company — originally known as Dawn AI — emerged to address what Hylak, a former Apple human interface designer, called the “black box problem” of AI performance, helping teams catch failures “as they happen and explain to enterprises what went wrong and why." At the time, Hylak described how “AI products fail constantly—in ways both hilarious and terrifying,” noting that unlike traditional software, which throws clear exceptions, “AI products fail silently.” Raindrop’s original platform focused on detecting those silent failures by analyzing signals such as user feedback, task failures, refusals, and other conversational anomalies across millions of daily events.

Silent failures used to be the norm. Raindrop’s Experiments changes that. It closes the loop between observation and action, turning raw signals into repeatable, measurable tests.

Teams can now ask, and answer, whether an update actually improves the agent or quietly breaks it. That’s not just visibility. That’s the difference between guessing and knowing.

And in a world where AI regressions compound invisibly, knowing is the only edge worth having.

Common Questions Answered

How does Raindrop help AI engineering teams improve their machine learning agent testing?

Raindrop provides an AI infrastructure platform that enables teams to track and understand performance variations across different AI agent iterations. The platform offers observability tools and an Experiments feature that allows developers to systematically monitor regressions and outcomes, bringing more discipline to AI model development.

What specific problem is Raindrop trying to solve in AI agent development?

Raindrop addresses the challenge of understanding why AI agents suddenly perform differently across iterations, which has traditionally been a messy and imprecise process. By creating an experimentation platform that simplifies data interpretation, the startup aims to help engineering teams approach AI testing with the same rigor as traditional software deployment.

What makes Raindrop's approach to AI testing unique in the current market?

Raindrop is one of the first AI-native observability platforms that focuses on helping enterprises monitor and understand generative AI system behaviors. Their platform encourages AI teams to track outcomes, share insights, and proactively address potential regressions before they become significant problems in AI model development.

LIVE03:21OpenAI's Miles Wang in Talks for USD 2B AI Drug Discovery Startup